781 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
partners and competitors to the consummation of the transaction and/or potential difficulties in employee retention as a result of the consummation
SC TO-T/A
EX-99
RYZB
RayzeBio Inc.
23 Feb 24
Third party tender offer statement (amended)
7:34am
to the consummation of the proposed transaction and/or potential difficulties in employee retention as a result of the consummation of the proposed transaction
424B5
6d2g3 xcrfm8s
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
sz4584
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T/A
EX-99
2y621ijb
12 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.1
uyr29xv
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
7tc0y1
25 Jan 24
Third party tender offer statement
8:13am